BIO-key International, Inc. (NASDAQ:BKYI) Q4 2022 Earnings Call Transcript

Cecilia Welch: Yes, so I’m just going from the K, which gives me annual. So the stock comp was a $388,000, outstanding shares are a little over $9.2 million.

Jack Vander Aarde: Great. And just for clarity, is the 10-K going to be coming out today? I don’t think I’ve seen it quite yet. But I imagine it’ll be file today?

Michael DePasquale: Jack, unfortunately, we found out yesterday that it likely will not get filed today. We’ll get filed next week. Unfortunately, our auditors — and you’re seeing this unfortunate, I suspect you see it as well across the board, just for shortage of resources and lack of resource, it’s been very difficult for the auditors to get through the process with the number of clients they have. Our audit firm was purchased by Marcum, mid last year. And so we have been transitioning into the new firm. And it’s just taken some extra time the last two quarters to get all of the work done again with the transition and resources. So, we will file, but we will file late.

Jack Vander Aarde: Okay, understand. And yes, I have seen — just to confirm, I have seen that across a lot of emerging growth companies as well. So that makes sense. Well, good. I’m happy to hear about your outlook for robust growth. That’s it for me. Thanks for the questions.

Michael DePasquale: Thank you, Jack.

Operator:

, :

Michael DePasquale: Thank you everyone for joining today’s call. We look forward to updating you on our Q1 call, which will be held in May. So it’s not too far away. And as usual, we’ll continue to provide regular updates via press releases for newsworthy developments as they happen. Once again, we thank you for taking the time to join us this morning. And have a great weekend everyone.

Operator: Conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.